Regulation of genes encoding NAD(P)H:quinone oxidoreductases

Free Radical Biology and Medicine

Volumn 29, Issue 3-4, 2000, Pages 254-262

  Jaiswal, Anil K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

c Jun; Free radicals; Gene expression; NAD(P)H:quinone oxidoreductase 1; Nrf2; Oxidative stress; Regulation

Indexed keywords

OXIDOREDUCTASE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIOXIDANT ACTIVITY; CARCINOGENESIS; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TISSUE SPECIFICITY;

EID: 0033800922     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00306-3     Document Type: Article

References (81)

1. Monks T.J., Hanzlik R.P., Cohen G.M., Ross D., Graham D.G. Quinone chemistry and toxicity. Toxicol. Appl. Pharm. 112:1992;2-16.
2. Radjendirane V., Joseph P., Jaiswal A.K. Gene expression of DT diaphorase (NQO1) in cancer cells. Forman H.J., Cadenas E. Oxidative stress and signal transduction. 1997;441-475 Chapman & Hall, New York.
3. Ernster L., Navazio F. Soluble diaphorases in animal tissues. Acta Chem. Scand. 12:1958;595.
4. Ernster L., Ljunggren M., Danielson L. Purification and some properties of a highly dicumarol-sensitive liver diaphorase. Biochem. Biophys. Res. Commun. 2:1960;88-92.
5. Hojeberg B., Blomberg K., Sternberg S., Lind C. Biospecific adsorption of hepatic DT diaphorase on immobilized dicumarol. Arch. Biochem. Biophys. 207:1981;205-216.
6. Raftell M., Blomberg K. Immunochemical studies on two DT diaphorase-active antigens isolated from rat liver cytosol by affinity chromatography. Arch. Biochem. Biophys. 199:1980;165-171.
7. Segura-Aguilar J., Kaiser R., Lind C. Separation and characterization of isoforms of DT diaphorase from rat liver cytosol. Biochem. Biophys. Acta. 1120:1992;33-42.
8. Prochaska H.J., Talalay P. Purification and characterization of two isofunctional forms of NAD(P)H:quinone reductase from mouse liver. J. Biol. Chem. 261:1986;1372-1378.
9. Edwards Y.H., Potter J., Hopkinson D.A. Human FAD-dependent NAD(P)H diaphorase. Biochem. J. 187:1980;429-436.
10. Shaw P.M., Reiss A., Adesnik M., Nebert D.W., Schembri J., Jaiswal A.K. The human dioxin-inducible NAD(P)H:quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4. Eur. J. Biochem. 195:1991;171-176.
11. Wu K.B., Knox R., Sun X.Z., Joseph P., Jaiswal A.K., Zhang D., Deng P.S.K., Chen S. Catalytic properties of NAD(P)H:quinone oxidoreductase 2 (NQO2), a dihydronicotinamide riboside-dependent oxidoreductase. Arch. Biochem. Biophys. 347:1997;221-228.
12. Zhao Q., Yang X.L., Holtzclaw W.D., Talalay P. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT diaphorase). Proc. Natl. Acad. Sci. USA. 94:1997;1669-1674.
13. Robertson J.A., Chen H.C., Nebert D.W. NAD(P)H:menadione oxidoreductase novel purification of enzyme. CDNA and complete aminoacid sequnce and gene regulation . J. Biol. Chem. 261:1986;15794-15799.
14. Williams J.B., Lu A.Y.H., Cameron R.G., Pickett C.B. Rat liver NAD(P)H:quinone reductase construction of a quinone reductase cDNA clone and regulation of quinone reductase mRNA by 3-methycholantherene and in persistent hepatocyte nodules induced by chemical carcinogenesis . J. Biol. Chem. 261:1986;5524-5528.
15. Bayney R.M., Morton M.R., Favreau L.V., Pickett C.B. Rat liver NAD(P)H:quinone reductase regulation of quinone reductase gene expression by planar aromatic compounds and determination of the exon structure of the quinone reductase structural gene . J. Biol. Chem. 264:1989;21793-21797.
16. Jaiswal A.K., McBride O.W., Adensik M., Nebert D.W. Human dioxin-inducible cytosolic NAD(P)H:quinone oxidoreductase. J. Biol. Chem. 263:1988;13572-13578.
17. Jaiswal A.K. Human NAD(P)H:quinone oxidoreductase gene structure and induction by dioxin. Biochemistry. 30:1991;10647-10653.
18. Ernster L. DT diaphorase a historical review . Chem. Scripta. 27A:1987;1-13.
19. Fahey J.W., Holtzclaw W.D., Prestera T., Zhang Y., Talalay P. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol. Lett. 82, 83:1995;173-179.
20. Riley R.J., Workman P. DT diaphorase and cancer chemotherapy. Biochem. Pharm. 43:1992;1657-1669.
21. Joseph P., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) specifically prevents the formation of benzo(a)pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. USA. 91:1994;8413-8417.
22. Lind C., Hochstein P., Ernster L. DT diaphorase properties, reaction mechanism, metabolic function. A progress report . King T.E., Mason H.S., Morrison M. Oxidases and related redox systems. 1982;321-347 Pergamon Press, Oxford.
23. Chesis P.L., Levin D.E., Smith M.T., Ernster L., Ames B.N. Mutagenicity of quinones pathways of metabolic activation and detoxification . Proc. Natl. Acad. Sci. USA. 81:1984;1696-1700.
24. Brunmark A., Cadenas E., Segura-Aguilar J., Lind C., Ernster L. DT diaphorase catalyzed two-electron reduction of various p-benzoquinone- and 1,4-naphthoquinone epoxides. Free Radic. Biol. Med. 5:1988;133-143.
25. De Flora A. Prominent role of DT diaphorase as a cellular mechanism reducing chromium (VI) and reverting its mutagenicity. Cancer Res. 45:1985;3188-3196.
26. Hakura A., Mochida H., Tsutsi Y., Yamatsu K. Mutagenicity and cytotoxicity of naphthoquinones for Ames Salmonella Tester Strains. Chem. Res. Toxicol. 7:1994;559-567.
27. Hakura A., Mochida H., Tsutsi Y., Kamatsu K. Mutagenicity of benzoquinones for Ames Salmonella Tester Strains. Mutat. Res. 347:1995;37-43.
28. Joseph P., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 (NQO1) reduces the mutagenicity of DNA caused by NAD(P)H:P450 reductase-activated metabolites of benzo(a)pyrene quinones. Br. J. Canc. 77:1998;709-719.
29. Joseph P., Klein-Szanto A.J.P., Jaiswal A.K. Hydroquinones cause specific frame shift mutations involving deletion of a single cytosine from the DNA sequence 5′-CCCCC-3′ and lead to cellular transformation and in vivo tumorigenesis. Br. J. Canc. 78:1998;312-320.
30. Radjendirane V., Joseph P., Lee Y.H., Kimura S., Klein-Sazanto A.J.P., Gonzalez F.J., Jaiswal A.K. Disruption of the DT diaphorase (NQO1) in mice leads to increased menadione toxicity. J. Biol. Chem. 273:1998;7382-7389.
31. Jaiswal A.K., Burnett P., Adesnik M., McBride O.W. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry. 29:1990;1899-1906.
32. Jaiswal A.K. Human NAD(P)H:quinone oxidoreductase 2 gene structure and tissue specific expression . J. Biol. Chem. 269:1994;14502-14508.
33. Jaiswal A.K., Bell D.W., Radjendirane V., Testa J.R. Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphism. Pharmacogenetics. 9:1999;413-418.
34. Ross D., Beall H., Traver R.D., Siegel D., Phillips R.M., Gibson N.W. Bioactivation of quinones by DT diaphorase, molecular, biochemical, and chemical studies. Oncol. Res. 6:1994;493-500.
35. Rauth A.M., Goldberg Z., Misra V. DT diaphorase possible roles in cancer chemotherapy and carcinogenesis . Oncol. Res. 9:1997;339-349.
36. Workman P. Enzyme-directed bioreductive drug development revisted. A commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes particularly DT diaphorase. Oncol. Res. 6:1994;461-475.
37. Ernster L. DT diaphorase. Meth. Enzymol. 186:1990;287-301.
38. Cresteil T., Jaiswal A.K., Eisen H.J. Transcriptional control of human cytochrome P1-450 (CYP 1A1) gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in human tissue culture cell lines. Arch. Biochem. Biophys. 253:1987;233-240.
39. Rushmore T.H., Pickett C.B. Glutathione s-transferase structure, regulation, and therapeutic implications. J. Biol. Chem. 268:1993;11475-11478.
40. Nebert D.W. Drug-metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. 47:1994;25-37.
41. Daniel V., Sharon R., Bensimon A. Regulatory elements controlling the basal and drug- inducible expression of glutathione s-transferase Ya subunit gene. DNA. 8:1989;399-408.
42. Jaiswal A.K. Antioxidant response element. Biochem. Pharmacol. 48:1994;439-444.
43. Hayes J.D., Strange R.C. Potential contribution of the glutathione s-transferase supergene family to resistance to oxidative stress. Free Radic. Res. 22:1995;193-207.
44. Pickett C.B., Lu A.Y.H. Glutathione s-transferases gene structure, regulation, and biological function . Ann. Rev. Biochem. 58:1989;743-764.
45. Tsuchida S., Sato K. Glutathione transferases and cancer. Crit. Rev. Biochem. Molec. Biol. 27:1992;337-384.
46. Tephly T., Burchell B. UDP-glucuronosyl transferase a family of detoxifying enzymes . Trends Pharm. 11:1990;276-279.
47. Oesch F., Gath I., Igarashi T., Glatt H.R., Thomas H. Arinc E., Schenkman J.B., Hodgson E. Molecular aspects of monooxygenases and bioactivation of toxic compounds. 1991;447-461 Plenum, New York.
48. Mulkahy R.T., Wartman M.A., Bailey H.H., Gipp J.J. Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J. Biol. Chem. 272:1997;7445-7454.
49. Wattenburg L.W. Inhibition of neoplasia by minor dietary constituents. Cancer Res. 43:1983;2448s-2453s.
50. Wattenburg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
51. Zhang Y., Talalay P., Cho C., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli isolation and elucidation of structure . Proc. Natl. Acad. Sci. USA. 89:1992;2399-2403.
52. Zhang Y., Kensler T.W., Cho C., Posner G.H., Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA. 91:1994;3147-3150.
53. Li Y., Jaiswal A.K. Regulation of human NAD(P)H:quinone oxidoreductase gene role of AP-1 binding site contained within human antioxidant response element . J. Biol. Chem. 267:1992;15097-15104.
54. Xie T., Belinsky M., Xu Y., Jaiswal A.K. ARE- and TRE-mediated regulation of gene expression response to xenobiotics and antioxidants . J. Biol. Chem. 270:1995;6894-6900.
55. Rushmore T.H., King R.G., Paulson K.E., Pickett C.B. Regulation of glutathione s- transferase Ya subunit gene expression identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds . Proc. Natl. Acad. Sci. USA. 87:1990;3826-3830.
56. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione s-transferase Ya subunit gene characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants . J. Biol. Chem. 265:1990;14648-14653.
57. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:1991;11632-11639.
58. Friling R.S., Bensimon A., Tichauer Y., Daniel V. Xenobiotic-inducible expression of murine glutathione s-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. USA. 87:1990;6258-6262.
59. Friling R.S., Bergelson S., Daniel V. Two adjacent AP-1-like binding sites form the electrophile responsive element of the murine glutathione S-transferase Ya subunit gene. Proc. Natl. Acad. Sci. USA. 89:1992;668-672.
60. Okuda A., Imagawa M., Maeda Y., Sakai M., Muramatsu M. Functional cooperativity between two TPA responsive elements in undifferentiated F9 embryonic stem cells. EMBO J. 9:1990;1131-1135.
61. Angel P., Karin M. The role of Jun, Fos and AP-1 complex in cell proliferation and transformation. Biochem. Biophys. Acta. 1072:1991;129-157.
62. Prestera T., Holtzclaw W.D., Zhang Y., Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA. 90:1993;2965-2969.
63. Wasserman W., Fahl W.E. Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. USA. 94:1997;5361-5366.
64. Bergelson S., Pinkus R., Daniel V. Induction of AP-1 (Fos/Jun) by chemical agents mediates activation of glutathione s-transferase and quinone reductase gene expression. Oncogene. 9:1994;565-571.
65. Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. USA. 93:1996;14960-14965.
66. Liu S., Pickett C.B. The rat liver glutathione s-transferase Ya subunit gene characterization of the binding properties of a nuclear protein from Hep-G2 cells that has high affinity for the antioxidant response element . Biochemistry. 35:1996;11517-11521.
67. Vasliou V., Puga A., Chang C., Tabor M.W., Nebert D.W. Interaction between the Ah-receptor and proteins binding to the AP-1-like electrophile response element (EpRE) during murine phase II [Ah] battery gene expression. Biochem. Pharm. 12:1995;2057-2068.
68. Yoshioka K., Deng T.L., Cavigelli M., Karin M. Antitumor promotion by phenolic antioxidants inhibition of AP-1 activity through induction of Fra expression . Proc. Natl. Acad. Sci. USA. 92:1995;4972-4976.
69. Montano M.M., Jaiswal A.K., Katzenellenbogen B.S. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor α and estrogen receptor β J. Biol. Chem. 273:1998;25443-25449.
70. Venugopal R., Jaiswal A.K. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 17:1998;3145-3156.
71. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh K., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:1997;313-322.
72. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:1999;76-86.
73. Wilkinson J. IV, Radjendirane V., Pfeiffer G.R., Jaiswal A.K., Clapper M.L. Disruption of c-Fos leads to increased expression of NAD(P)H:quinone oxidoreductase 1 and glutathione s-transferase. Biochem. Biophys. Res. Commun. 253:1998;855-858.
74. Marini M.G., Chan K., Casula L., Kan Y.W., Cao A., Moi P. HMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J. Biol. Chem. 272:1997;16490-16497.
75. 1-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis. 8:1987;1549-1553.
76. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutathione s-transferase gene expression. J. Biol. Chem. 271:1996;13422-13429.
77. Favreau L.V., Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 266:1991;4556-4561.
78. Li Y., Jaiswal A.K. Human antioxidant response element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression effect of sulfhydryl modifying agents . Eur. J. Biochem. 226:1994;31-39.
79. Demple B., Amabile-Cuevas C.F. Redox redux the control of oxidative stress responses . Cell. 67:1991;837-839.
80. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor . EMBO J. 12:1993;2005-2015.
81. Zheng M., Aslund F., Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science. 279:1998;1718-1721.